Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

1.

Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand.

Anunnatsiri S, Towiwat P, Chaimanee P.

Southeast Asian J Trop Med Public Health. 2012 Sep;43(5):1169-77.

PMID:
23431823
[PubMed - indexed for MEDLINE]
2.

Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.

Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM.

Am J Infect Control. 2007 Nov;35(9):606-12.

PMID:
17980240
[PubMed - indexed for MEDLINE]
3.

Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.

J Antimicrob Chemother. 2006 Apr;57(4):780-3. Epub 2006 Feb 21.

PMID:
16492721
[PubMed - indexed for MEDLINE]
Free Article
4.

Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.

Park SH, Choi SM, Lee DG, Kim J, Choi JH, Kim SH, Kwon JC, Yoo JH.

Microb Drug Resist. 2011 Dec;17(4):537-44. doi: 10.1089/mdr.2011.0072. Epub 2011 Aug 29.

PMID:
21875342
[PubMed - indexed for MEDLINE]
5.

Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland.

Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, Ledergerber B, Weber R.

Infection. 2010 Feb;38(1):33-40. doi: 10.1007/s15010-009-9207-z. Epub 2010 Jan 27.

PMID:
20108162
[PubMed - indexed for MEDLINE]
6.

Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.

Huang Y, Zhuang S, Du M.

Infection. 2007 Oct;35(5):339-45. Epub 2007 Aug 25.

PMID:
17721736
[PubMed - indexed for MEDLINE]
7.

Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A; Spanish Network for Research in Infectious Diseases (REIPI).

Clin Infect Dis. 2010 Jan 1;50(1):40-8. doi: 10.1086/649537.

PMID:
19995215
[PubMed - indexed for MEDLINE]
Free Article
8.

Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.

Meier S, Weber R, Zbinden R, Ruef C, Hasse B.

Infection. 2011 Aug;39(4):333-40. doi: 10.1007/s15010-011-0132-6. Epub 2011 Jun 25.

PMID:
21706226
[PubMed - indexed for MEDLINE]
9.

Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.

Peña C, Gudiol C, Calatayud L, Tubau F, Domínguez MA, Pujol M, Ariza J, Gudiol F.

J Hosp Infect. 2008 Feb;68(2):116-22. doi: 10.1016/j.jhin.2007.11.012. Epub 2008 Jan 15.

PMID:
18226420
[PubMed - indexed for MEDLINE]
10.

Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.

Apisarnthanarak A, Kiratisin P, Mundy LM.

Infect Control Hosp Epidemiol. 2008 Nov;29(11):1026-34. doi: 10.1086/591864.

PMID:
18947321
[PubMed - indexed for MEDLINE]
11.

Risk factors for extended-spectrum beta-lactamase-producing Escherichia coli infection in hospitalized patients.

Ikeda Y, Mamiya T, Nishiyama H, Koseki T, Mouri A, Nabeshima T.

Nagoya J Med Sci. 2012 Feb;74(1-2):105-14.

PMID:
22515116
[PubMed - indexed for MEDLINE]
12.

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, de Cueto M, Ríos MJ, Hernández JR, Pascual A.

Clin Infect Dis. 2006 Dec 1;43(11):1407-14. Epub 2006 Oct 25.

PMID:
17083012
[PubMed - indexed for MEDLINE]
Free Article
13.

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Shin SY; Korean Network for Study of Infectious Diseases (KONSID).

Int J Antimicrob Agents. 2010 Sep;36(3):284-7. doi: 10.1016/j.ijantimicag.2010.05.009. Epub 2010 Jun 30.

PMID:
20580534
[PubMed - indexed for MEDLINE]
14.

Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Ena J, Arjona F, Martínez-Peinado C, López-Perezagua Mdel M, Amador C.

Urology. 2006 Dec;68(6):1169-74.

PMID:
17169640
[PubMed - indexed for MEDLINE]
15.

Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.

Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL.

Antimicrob Agents Chemother. 2012 Feb;56(2):618-22. doi: 10.1128/AAC.05753-11. Epub 2011 Nov 28.

PMID:
22123694
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].

Angel Díaz M, Ramón Hernández J, Martínez-Martínez L, Rodríguez-Baño J, Pascual A; Grupo de Estudio de Infección Hospitalaria (GEIH).

Enferm Infecc Microbiol Clin. 2009 Nov;27(9):503-10. doi: 10.1016/j.eimc.2008.09.006. Epub 2009 Mar 28. Spanish.

PMID:
19329230
[PubMed - indexed for MEDLINE]
17.

Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.

Kang CI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, Lee NY, Song JH.

J Clin Microbiol. 2012 Feb;50(2):312-7. doi: 10.1128/JCM.06002-11. Epub 2011 Dec 7.

PMID:
22162561
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.

Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.

Antimicrob Agents Chemother. 2004 Dec;48(12):4574-81.

PMID:
15561828
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.

Khanfar HS, Bindayna KM, Senok AC, Botta GA.

J Infect Dev Ctries. 2009 May 1;3(4):295-9.

PMID:
19759493
[PubMed - indexed for MEDLINE]
Free Article
20.

Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.

Skippen I, Shemko M, Turton J, Kaufmann ME, Palmer C, Shetty N.

J Hosp Infect. 2006 Oct;64(2):115-23. Epub 2006 Jul 21.

PMID:
16859810
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk